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ABSTRACT
Deletion mutants at the amino- and carboxyl-ends of the 029
terminal protein, as well as internal deletion and substitution
mutants, whose ability to prime the initiation of 929 DNA
replication was affected to different extent, have been assayed
for their capacity to interact with DNA or with the 929 DNA poly-
merase. One DNA binding domain at the amino end of the terminal
protein has been mapped. Two regions involved in the binding to
the DNA polymerase, an internal region near the amino-terminus
and a carboxyl-terminal one, have been also identified.
Interaction with both DNA and 029 DNA polymerase are required to
led to the formation of terminal protein-dAMP initiation complex
to start 029 DNA replication.
INTRODUCTION
Bacteriophage p29, which infects Bacillus subtilis, has a
linear, double-stranded DNA 19285 bp long (1) with the viral
protein p3 covalently linked to the 5' ends by a phosphoester
bond between the OH group of serine residue 232 and dAMP, the
terminal nucleotide at both 5' ends (2-4). The terminal protein
p3, 266 amino acids long, primes the initiation of replication at
either i29 DNA end by formation of a covalent complex with dAMP,
which is elongated by a strand-displacement mechanism (5-7). An
in vitro replication system with purified proteins has been
developed in which the 029 DNA polymerase catalyzes the formation
of the terminal protein-dAMP covalent complex in the presence of
either p3-DNA (8,9) or protein-free templates containing i29 DNA
replication origins (10,11). The protein p3-dAMP initiation
complex is elongated by the p29 DNA polymerase to produce full-
length i29 DNA in a very processive way (12,13). A complex
between the terminal protein and the DNA polymerase is formed in
the presence of NH4+ ions, which stimulate i29 DNA replication
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(14). In addition, the viral protein p6, that binds to the 929
DNA ends (15,16), stimulates the initiation reaction (17), as
well as the transition from initiation to elongation (18).
Deletion mutants at the amino- and carboxyl-ends of the
terminal protein, as well as internal deletion and substitution
mutants have been constructed and their priming capacity studied
(19-21). In this paper we report the correlation of the priming
activity of the mutant proteins with the capacity to interact
with the 329 DNA polymerase or with DNA, defining functional
domains in the terminal protein for such interactions.
MATERIALS AND METHODS
a) Protein p3 mutants
Construction of the recombinant plasmids encoding the
protein p3 mutants used in this work, nucleotide sequence
determination, deduced amino acid sequence and priming capacity
of the mutants have been described (see Table I for references).
The nomenclature for the protein p3 mutants is based on the
suggestions of Wetzel (22), but designating the initiator Met as
position 1 of the sequence, the last residue of protein p3
corresponding to position 266. With these rules, the proteins
deleted at the amino end (20) will be named as p3(A2-n), being
residues 2 and n included in the deletion. Residues introduced by
the process of plasmid construction, as in the cases of C-termi-
nal (19) and internal (21) deletions, will be indicated with the
residue number of the first added amino acid noted; for example,
the deleted proteins encoded by plasmids pRMcn385 and pAZci315,
in which a glycine residue is added, are named p3(A241-261/+241G)
and p3(A56-71/+56G), respectively. The list of the p3 mutants
used is shown in Table I.
b) Protein purification
Overproduction of the wild-type and mutant p3 proteins gives
rise to the formation of insoluble aggregates. Purification of
the proteins from the latter was done as described by Zaballos et
al. (21). Essentially the procedure involves protein extraction
with 2 M guanidine hydrochloride (GuHCl1, renaturation by dialy-
sis against 1 M NaCl buffer and a single chromatographic step on
a phosphocellulose column. In some cases (see Results, section a)
DNA was also recovered in the GuHCl extraction, being removed by
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Table I. Protein p3 deletion mutants used in this work
Protein Plasmid initiation, % Reference
p3 wt pRMn7 100 20
p3(A2-6) pAZa3O5 90 "
p3(A2-9) pAZa3O8 40 "
p3(A2-10) pAZa3O9 50 "
p3(A2-12) pAZa311 60 "
p3(A2-14) pAZa313 30 "
p3(A2-18) pAZa317 <5 "
p3(A2-37) pAZa336 <5 "
p3(A2-55) pAZa354 ub
p3( ,_,,,)a pRMn7 u 21
p3(A30-51/+49GDL) pAZai319 <5 "
p3(A56-71/+56G) pAZci315 <5 "
p3(A56-80/+56G) pAZci324 u "
p3(A263-266) pRMn25H3 50 19
p3(A241-261/+241G) pRMcn385 u "
p3(A229-261/+229G) pRMcn392 u "
ap3(A1-111) is a protein from an internal translational start in
the gene 3 reading frame, characterized by amino acid sequencing
bof its N-terminus (21).
u indicates that the initiation complex was undetected.
addition of polyethyleneimine.
c) Protein p3-DNA polymerase interaction assay
Wild-type or mutant protein p3 was incubated, in 0.2 ml,
with 029 DNA polymerase (0.2-0.6 pg of each protein; molar ratio
2:1) for 1 h at 0°C in a buffer containing 50 mM Tris-HCl, pH
7.5, 44 mM NaCl and 20 mM (NH4)2SO4. The samples were layered on
top of 5 ml linear 15-30% glycerol gradients in the above buffer
and centrifuged for 28 h at 290000 x g at 0°C. Fractions of about
0.2 ml were collected from the bottom and protein p3 and DNA
polymerase detected by radioimmunoassay as described (23).
d) Analysis of protein p3-DNA complexes
1) Gel retardation assay
Wild-type or mutant protein p3 (10-40 ng) was incubated with
2 ng of a 32P-labelled DNA fragment 450 bp long (positions 4502-
4591 from 929 DNA) for 30 min at 0°C in a 25 pl mixture contai-
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ning 12 mM Tris-acetate, pH 7.4 and 1 mM EDTA. The protein-DNA
complexes were resolved by electrophoresis in 4% polyacrylamide
gels at 40C in the above buffer as described (24) and detected by
autoradiography.
2) Glycerol gradient centrifugation
Wild-type or mutant protein p3 (0.25-0.6 pg) was incubated,
in 0.2 ml, with 20 pg of proteinase K-treated 929 DNA (25) for 1
h at 0°C in a buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM
MgCl2 and 75 mM NaCl. Samples were centrifuged for 4 h as des-
cribed in c; protein p3 was detected by radioinmunoassay and DNA
by agarose gel electrophoresis followed by ethidium bromide
staining.
e) In vitro initiation and replication assays
The incubation mixture for the initiation reaction
contained, in 25 pl, 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 20 mM
(NH4)2S04, 5% glycerol, 0.25 pM [a-3 P]dATP (400 Ci/mmol), 0.5 pg
of 929 DNA-protein p3 complex as template, 12.5 ng of purified
V29 DNA polymerase (8) and 5-10 ng of wild-type or mutant protein
p3. When indicated, 2.5 pg of purified protein p6 (17) and NaCl
were added. When protein-free templates (11) were used,
[o-32P]dATP concentration was raised to 0.5 pM, 029 DNA polyme-
rase to 25 ng and protein p3 to 40-80 ng. After 10 min at 300C,
the reaction was stopped by adding EDTA to 10 mM and heating for
10 min at 680C, and the samples were treated with 25 units of
micrococcal nuclease for 45 min at 370C and filtered through
Sephadex G-50 spun columns in the presence of 0.1% SDS. The
excluded fractions were subjected to SDS-electrophoresis in 15%
polyacrylamide gels (26) and the p3-dAMP initiation complex was
detected by autoradiography.
For the replication assays, 20 pM each dNTP was added to the
above reaction mixture, the reaction was stopped with SDS to
0.1%, filtered as above and the Cerenkov radiation of the
excluded fractions was counted. The samples were subjected to
alkaline 0.7% agarose gel electrophoresis as described (27).
RESULTS
a) Purification of the p3 mutant proteins
In the purification of the p3 mutant proteins, differences
in two steps of the process were observed: the presence of DNA in
the fraction extracted with GuHCl and the strength of binding to
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Figure 1. Interaction of the p3 mutant proteins with DNA deter-
mined y gel retardation. The indicated amounts of wilq-typeprotein p3 or deletion mutants were incubated with a P-labelled
DNA fragment as described in Materials and Methods. After elec-
trophoresis the DNA bands were detected by autoradiography. The
arrow indicates the position of free DNA.
the phosphocellulose matrix. Wild-type protein p3, C-terminal
deletion mutants and N-terminal deletion mutants up to 11 amino
acids were coextracted with DNA from the insoluble aggregates and
eluted from phosphocellulose at 0.6 M NaCl. N-terminal mutants
with deletions higher than 11 amino acids were not coextracted
with DNA and showed an inversal correlation between the extent of
the deletion and the ionic strength needed for elution from phos-
phocellulose; thus, p3(A2-14) eluted between 0.4 and 0.6 M NaCl,
p3(A2-18) at 0.4 M NaCl and p3(A2-37), p3(62-56) and p3(A1-111)
were not fixed to the matrix at 0.2 M NaCl. On the other hand,
the internal deletion proteins, p3(A30-51/ +49GDL), p3(A56-71/
+56G) and p3(A56-80/+56G), eluted at 0.4 M NaCl (results not
shown). Taking into account that phosphocellulose behaves as an
affinity matrix for proteins that bind to nucleic acids, the
purification of the p3 mutant proteins gave an indirect evidence
about the location of a potential DNA-binding domain in the
N-terminal portion of protein p3.
b) Interaction of the p3 mutant proteins with double-stranded DNA
Protein p3 interacts with double-stranded DNA (28,29) and
this property could be important for the priming function of the
protein. To determine the location of the potential DNA-binding
domain, the interaction between different p3 deletion mutant
proteins and DNA was tested. Figure 1 shows a gel retardation
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Figure 2. Interaction between the p3 mutant proteins and DNA
determined by glycerol gradient centrifugation. Mutant proteins
were incubated with 029 DNA as described in Materials and Methods
and, after centrifugation, protein p3 was detected by radio-
immunoassay. Vertical arrows mark the position of the DNA peak.
Sedimentation was from right to left.
assay in which the mutant proteins p3(A2-lO) and p3(62-12) gave
rise to retarded DNA bands in a way similar to that of the wild-
type protein, whereas a higher amount of p3(62-14) was needed,
suggesting that p3(62-14) has a reduced affinity for DNA. By
glycerol gradient analysis (Fig 2), using conditions in which
most of the protein p3(A2-14) cosedimented with DNA, neither
protein p3(A2-18) nor the internally deleted proteins, (p3(A30-
51/+49GDL) and p3(A56-71/+56G)), were bound to DNA. On the other
hand, the C-terminal deletion mutant proteins, p3(A241-261/+241G)
and p3(A229-261/+229G), behaved as the wild-type protein in their
ability to interact with DNA (not shown). Therefore, three
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Figure 3. Detection by glycerol gradient centrifugation of the
complex between the p3 mutant proteins and the 929 DNA poly-
merase. The wild-type or mutant p3 proteins were incubated with
the #29 DNA polymerase as described in Materials and Methods and,
after centrifugation, the proteins in the different fractions
were detected by radioimmuinoassay. o-_o, protein p3; *--o,, DNA
polymerase. Vertical arrows mark the position of bovine serum
albumin (68 Kda). Sedimentation was from right to left.
regions at the N-terminal part of the p3 molecule comprised
between amino acids 13-18, 30-51 and 56-71 are involved in DNA
binding.
c) Interaction of the p3 mutant proteins with the 29 DNA
polymerase
It has been suggested that a tight association between
protein p3 and the p29 DNA polymerase occurs ini29-i fected
B.subtilis cells (30). In addition, in the presence of NH4+ ions,
these proteins interact in vitro to form an stable complex (14)
and stimulation of o29 DNA replication in vitro by NHtions has
B.subtlisclls(0). Inaddit n, i the pesenc f N4~ os
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been observed (12,14), suggesting a biological role for this
association. The p3 mutant proteins were incubated with the 929
DNA polymerase as indicated in Materials and Methods, section c,
and the relevant results are shown in Figure 3. At least, two
distant regions of protein p3 are involved in the interaction
with the i29 DNA polymerase. One of them is located in the
C-terminal portion of the molecule, defined by the interaction of
p3(A263-266) and the lack of interaction of p3(A241-261/+241G).
The other corresponds to an internal position near the N-termi-
nus, defined by the interaction of p3(A2-55) and p3(A56-71/+56G)
and the negative result obtained with p3(1-111) and
p3(A56-80/+56G) mutant proteins.
d) Activity of the p3 mutant proteins
We had previously shown the priming ability of the p3 mutant
proteins using either cell-free extracts or partially purified
proteins (see Table I). Those data correlate well with the
results presented here on the interaction with DNA or with the
,029 DNA polymerase. The proteins which do not bind to DNA, the
N-deleted proteins beyond the 17th residue and the internally
deleted proteins, primed the initiation reaction at a level less
than 5% that of the wild-type protein, and the proteins which do
not interact with the i29 DNA polymerase, p3(Al-111), p3(A56-80/
+56G) and p3(6241-261/+241G), were unable to form the initiation
complex p3-dAMP. No significant differences in priming ability
were found when the mutant proteins purified by GuHCl extraction
were tested in similar conditions of low salt (Table II and not
shown). However, the activity of the N-deleted mutant proteins,
p3(A2-6), p3(62-9), p3(A2-10) and p3(62-14), with a priming
ability similar to that of the wild-type protein at low salt,
decreased drastically when the in vitro reactions were carried
out at high salt (Table II). Interestingly, addition of the 929
protein p6, which changes the DNA conformation at the 029 repli-
cation origins (15), restored the amount of replication at 0.1 M
NaCl nearly to that obtained at low salt (Table II). On the other
hand, differences between the mutant proteins p3(A2-10),
p3(A2-12) and p3(A2-14) were observed when protein-free templates
were used in the initiation reaction (Fig. 4). Whereas the
priming ability of p3(62-10) and p3(A2-12) relative to the wild-
type protein did not differ significantly using either protein-
10360
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Table II. Effect of high salt and protein p6 on the ability
of p3 mutant proteins to prime P29 DNA replication.
Protein Activity, %a
4 mM NaCl 100 mM NaCl 100 mM NaCl
-protein p6 -protein p6 +protein p6
p3 wild-type 100c 100d 100e
p3(A2-6) 69 6 66
p3(A2-9) 80 9 90
p3(A2-10) 90 17 84
p3(A2-12) 76 8 82
p3(42-14) 67 4 69
aThe ability of the mutant proteins to prime 929 DNA-protein
p3 replication was assayed as described in Materials and
Methods (section e, replication assay) using 10 ng of
wild-type or mutant p3 proteins.
c,d,e 100% activity corresponds to 100, 5 and 75 pmols of
dAMlP incorporated, respectively.
free templates or p3-DNA, that of p3(A2-14) was greatly reduced
on protein-free templates.
DISCUSSION
a) DNA binding domain
From the results obtained, which are summarized in figure 5,
it can be concluded that the amino acid regions of protein p3
from positions 13 to 18, 30 to 51 and 56 to 71, deleted in the
mutant proteins p3(A2-18), p3(A30-51/+49GDL) and p3(A56-71/+56G),
respectively, are important for DNA binding and should contain
residues interacting with DNA or affecting the conformation of
the domain. However, the fact that this conclusion is constrained
by the availability of mutants and that all the mutants deleted
at the N-terminus have the DNA binding capacity affected in some
extent, suggests that all the above amino region is involved in
the interaction. Thus, N-deleted proteins up to residue 12,
although did not show difference in DNA binding compared with the
wild-type protein, were more salt-sensitive in the initiation
10361
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Figure 4. Priming ability of the p3 mutant proteins with
protein-free 029 DNA templates. A. The reaction for the formation
of the p3-dAMP complex was as described in Materials and Methods
using 29 ng of the 2364 bp long DraI A fragment from plasmid
pIA68 (11), containing 68 bp from the left 929 DNA end, with 80
ng of wild-type protein p3 or the indicated deletion mutant
proteins. After electrophoresis the p3-dAMP complex was detected
by autoradiography. B. As in A except that 80 ng of 929 DNA-pro-
tein p3 was used as template and the amount of wild-type or
mutant protein p3 was lowered to 10 ng.
reaction. Moreover, the 929 protein p6, that modifies the DNA
conformation at the replication origins, restored the activity,
suggesting that the binding of the mutant proteins to DNA at high
salt is somehow different to that of the wild-type p3, and proper
interactions may only take place when protein p6 is present.
Mutant protein p3(62-14) binds to DNA with diminished affinity
relative to p3(A2-12), and this could be reflected in the reduced
ability to prime replication with protein-free templates, whereas
the priming with the terminal protein-containing DNA is similar
to that of p3(62-12). Protein p3 mutants having deletions of 17
amino acids or longer at the amino end and the internally deleted
proteins had drastically reduced both binding to DNA and ability
to prime p3-DNA replication.
None of the typical structural motifs considered to be
responsible for sequence-specific DNA binding, helix-turn-helix
(31), zinc finger (32) and leucine zipper (33), are found in
protein p3. Since the interaction of protein p3 with DNA does not
seem to be sequence-specific (28), it is unlikely that hydrogen
bonding to bases plays a major role in such interaction, and
electrostatic bonds between phosphate groups and positively
10362
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Figure 5. Summary of the properties of the p3 mutant proteins.
Boxes show the size of the different mutant proteins relative to
the wild-type protein p3. Location of the KKKY sequence and of
the Ser232 are indicated. Priming activity values were from Table
I, except for p3(A2-10), p3(62-12) and p3(A2-14) (this paper).
ORI-DNA refers to the protein-free template containing the i29
left replication origin; u, undetected; nt, not tested.
charged amino acids may be more relevant. Looking at the charge
distribution along protein p3, there is a positive cluster at the
amino end (net charge +8 in the first 80 residues), being
slightly positive in the middle of the molecule and negatively
charged at the carboxyl region (34). In the positive cluster at
the amino end of protein p3, the sequence KKKY flanked by
aromatic and hydrophobic residues is present. Interestingly, a
similar amino acid region is shared by the a-like DNA polymerases
(35), being located at the C-terminus of these proteins, where
the DNA binding domain could reside (36). This kind of amino acid
side chains would allow both ionic and hydrophobic interactions
with the phosphate backbone and base rings of the DNA, respec-
tively. Our experimental data are in agreement with the idea that
the above region could contain the amino acids that interact with
DNA: on the one hand, the sequence KKKY is deleted in p3(630-51/
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+49GDL) with a loss of DNA binding capacity (see Fig. 5), and on
the other, four positively charged amino acids have been removed
in mutant p3(A2-12) and the binding to DNA is only slightly
affected. Moreover, structural predictions showed that the N-part
of the proposed DNA binding region could be ordered in protein p3
as an amphipatic a-helix that would not be formed in mutant
p3(A2-18) (20), explaining the drop in affinity for DNA and
priming ability of this mutant relative to p3(62-14). The
internal deletion of mutant p3(656-71/+56G) might also affect the
folding of the DNA binding domain, although direct interaction of
the deleted residues with DNA cannot be discarded.
b) The DNA polymerase binding domain
The unability to prime 929 DNA replication of terminal
protein mutants which do not interact with the 929 DNA polymerase
suggests that physical association of both proteins is needed to
initiate DNA replication. The detection of at least two separate
regions in protein p3 involved in the interaction, comprised
between amino acids 72-80 and 242-262, could indicate the exis-
tence of either two different domains interacting with the DNA
polymerase or a single domain composed of two or more parts of
the molecule. The fact that both regions are needed for the
interaction supports the latter possibility, unless these regions
are affecting the structure of some other part of the molecule.
The C-terminal region interacting with the DNA polymerase is
located next to the linking site, where the DNA polymerase cata-
lyzes the incorporation of dAMP. Point mutations at this site do
not affect the binding to the DNA polymerase (29; Garmendia, C.,
Hermoso, J.M. and Salas, M., submitted for publication), sug-
gesting that the linking site and the DNA polymerase binding
domain are physically separated.
c) New aspects of the protein-priming mechanism
There are several reasons to support the idea that the first
step in the initiation of 029 DNA replication is the association
of the terminal protein and the DNA polymerase: i) their genes
are located close to each other and probably transcribed into a
polycistronic mRNA (37,38), ii) a partially purified terminal
protein-DNA polymerase complex can be isolated from p29-infected
cells (30) and iii) the two proteins interact in vitro in the
absence of the p3-DNA template (14). Once the complex is formed,
recognition of the replication origins should take place. On the
10364
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template counterpart the main component which determines the
replication origin is the parental protein attached to the DNA
ends (39). Taking into account that linear p3-DNA is able to
circularize and to form concatemers due to protein-protein
interaction (2,40) it is likely that the interaction between the
terminal protein in the complex with the DNA polymerase and the
parental terminal protein attached to the DNA is needed for the
recognition. Here we show that the interaction of the terminal
protein with DNA is important for its priming function. In
agreement with the DNA sequence-independent interaction of
protein p3, it has been suggested that the replication origin is
recognized as a whole structure rather than trough interaction
with specific bases (11). It is likely that binding of the
terminal protein to DNA is needed to recognize the replication
origins or, at least, to locate precisely the terminal
protein-DNA polymerase complex at the replication origin.
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